Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE ...
Please provide your email address to receive an email when new articles are posted on . None of the largest U.S. insurers provide coverage for intragastric balloon or endoscopic sleeve gastroplasty.
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BALTIMORE -- ...
AUSTIN, TX / ACCESSWIRE / July 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...
The US Food and Drug Administration (FDA) has cleared for marketing the first devices indicated for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision, according to the ...
"If you've regained weight, lost too little, or developed complications after a gastric bypass, a gastric bypass revision may help. Using endoscopic or minimally invasive laparoscopic techniques, the ...
AUSTIN, TX, Jul 13, 2022 - (ACN Newswire) - Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...